A New Era in Stroke Prevention for Atrial Fibrillation

被引：2
作者：
Singer, Daniel E. [1 ]
Go, Alan S. [2 ]
机构：
[1] Massachusetts Gen Hosp, Div Gen Med, Clin Epidemiol Unit, Boston, MA 02114 USA
[2] Kaiser Permanente No Calif, Div Res, Oakland, CA USA
来源：
ARCHIVES OF INTERNAL MEDICINE | 2012年 / 172卷 / 08期
关键词：
WARFARIN; ANTICOAGULATION; DABIGATRAN; OUTCOMES; THERAPY;
D O I：
10.1001/archinternmed.2012.897
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：631 / 633
页数：4
相关论文
共 11 条
[1]   Current Trial-Associated Outcomes With Warfarin in Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation A Meta-analysis [J].
Agarwal, Shikhar ;
Hachamovitch, Rory ;
Menon, Venu .
ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (08) :623-631
[2]   Pharmacology and management of the vitamin K antagonists [J].
Ansell, Jack ;
Hirsh, Jack ;
Hylek, Elaine ;
Jacobson, Alan ;
Crowther, Mark ;
Palareti, Gualtiero .
CHEST, 2008, 133 (06) :160S-198S
[3]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[4]   Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].
Granger, Christopher B. ;
Alexander, John H. ;
McMurray, John J. V. ;
Lopes, Renato D. ;
Hylek, Elaine M. ;
Hanna, Michael ;
Al-Khalidi, Hussein R. ;
Ansell, Jack ;
Atar, Dan ;
Avezum, Alvaro ;
Cecilia Bahit, M. ;
Diaz, Rafael ;
Easton, J. Donald ;
Ezekowitz, Justin A. ;
Flaker, Greg ;
Garcia, David ;
Geraldes, Margarida ;
Gersh, Bernard J. ;
Golitsyn, Sergey ;
Goto, Shinya ;
Hermosillo, Antonio G. ;
Hohnloser, Stefan H. ;
Horowitz, John ;
Mohan, Puneet ;
Jansky, Petr ;
Lewis, Basil S. ;
Luis Lopez-Sendon, Jose ;
Pais, Prem ;
Parkhomenko, Alexander ;
Verheugt, Freek W. A. ;
Zhu, Jun ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992
[5]   Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation [J].
Patel, Manesh R. ;
Mahaffey, Kenneth W. ;
Garg, Jyotsna ;
Pan, Guohua ;
Singer, Daniel E. ;
Hacke, Werner ;
Breithardt, Guenter ;
Halperin, Jonathan L. ;
Hankey, Graeme J. ;
Piccini, Jonathan P. ;
Becker, Richard C. ;
Nessel, Christopher C. ;
Paolini, John F. ;
Berkowitz, Scott D. ;
Fox, Keith A. A. ;
Califf, Robert M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10) :883-891
[6]   Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48) [J].
Ruff, Christian T. ;
Giugliano, Robert P. ;
Antman, Elliott M. ;
Crugnale, Sharon E. ;
Bocanegra, Tomas ;
Mercuri, Michele ;
Hanyok, James ;
Patel, Indravadan ;
Shi, Minggao ;
Salazar, Dan ;
McCabe, Carolyn H. ;
Braunwald, Eugene .
AMERICAN HEART JOURNAL, 2010, 160 (04) :635-U266
[7]   Antithrombotic therapy in atrial fibrillation [J].
Singer, Daniel E. ;
Albers, Gregory W. ;
Dalen, James E. ;
Fang, Margaret C. ;
Go, Alan S. ;
Halperin, Jonathan L. ;
Lip, Gregory Y. H. ;
Manning, Warren J. .
CHEST, 2008, 133 (06) :546S-592S
[8]   Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation? The ATRIA Study [J].
Singer, Daniel E. ;
Chang, Yuchiao ;
Fang, Margaret C. ;
Borowsky, Leila H. ;
Pomernacki, Niela K. ;
Udaltsova, Natalia ;
Go, Alan S. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (04) :297-U30
[9]   Dabigatran Association With Higher Risk of Acute Coronary Events Meta-analysis of Noninferiority Randomized Controlled Trials [J].
Uchino, Ken ;
Hernandez, Adrian V. .
ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (05) :397-402
[10]   Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control - Results from SPORTIF III and IV [J].
White, Harvey D. ;
Gruber, Michael ;
Feyzi, Jan ;
Kaatz, Scott ;
Tse, Hung-Fat ;
Husted, Steen ;
Albers, Gregory W. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (03) :239-245
12